FDA Approves DaTscan Imaging

January 2011 Monthly Message

- PAN Joins Class-Action Lawsuit Against Medicare
- FDA Approves DaTscan Imaging
- Letter from Merck About Sinemet
- Register for the PAN Forum Webcast
- Parkinson's in the Media



The Food and Drug Administration (FDA) approved DaTscan, a new radiopharmaceutical agent used for brain imaging.  With FDA’s approval on January 14, 2011, the Parkinson’s community now has an available brain imaging technology that can help in the diagnosis of Parkinson’s disease at an earlier stage and can help differentiate Parkinson’s from other conditions, such as essential tremor.  In early 2010, the Parkinson's Action Network wrote to FDA Commissioner Dr. Margaret Hamburg in support of DaTscan’s approval and classification.

Click here to read GE Healthcare’s press release regarding DaTscan’s approval.
Click here to read a news article regarding the approval.